Agile, Data-Driven Life Cycle Management for Continuous Manufacturing
ISPE
JULY 6, 2023
1 , 4 A Retrospective Journey In 2015, Vertex’s Orkambi was the first approved drug produced under a CM process for the treatment of cystic fibrosis. Pharma Investment Trend Report: What We’re Watching in 2023.” Published 13 January 2023. Updated 10 January 2023. This is demonstrated by the rise from $1.05 Zydney, and J.
52 
Let's personalize your content